Pelvic inflammatory disease cost-effectiveness of therapy: Difference between revisions
m Changes made per Mahshid's request |
Category |
||
Line 16: | Line 16: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Gynecology]] |
Revision as of 19:38, 21 September 2017
Pelvic inflammatory disease Microchapters |
Differentiating Pelvic Inflammatory Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Pelvic inflammatory disease cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Pelvic inflammatory disease cost-effectiveness of therapy |
FDA on Pelvic inflammatory disease cost-effectiveness of therapy |
CDC on Pelvic inflammatory disease cost-effectiveness of therapy |
Pelvic inflammatory disease cost-effectiveness of therapy in the news |
Blogs on Pelvic inflammatory disease cost-effectiveness of therapy |
Risk calculators and risk factors for Pelvic inflammatory disease cost-effectiveness of therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.